The Healthcare & Pharmaceuticals Committee aims to promote innovation and improved patient outcomes in Hong Kong. It creates a forum for healthcare organizations, providers and suppliers of healthcare products and services to engage on issues impacting the healthcare environment in Hong Kong. Our objective is to improve patient outcomes while supporting the Government’s objective of innovation.
With the expansion of 3 Vice-Chair position, we will focus on (1) Digital Health (2) Improving Access to Innovative Care, and (3) Hong Kong – GBA collaboration shaping opportunities.
The committee membership is open to corporate representatives from across the healthcare, insurance, legal, and tech sectors among others; licensed conventional and alternative health care practitioners; patient advocacy groups; and other interested parties.